Impact Factor
4.43
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
8.61
1,713 total citations
h5-index
50
h5 depth signal
Cited share
90.0%
188 of 209
Total citations
1,713
Citation footprint
Metric signal
9.38
External metric anchor
Self-citation
0.6%
10 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
637
United States
244
India
106
Iran
85
Brazil
67
Citing Fields of Research
Neurodegenerative Disorders
553
Neurosciences
293
Cell Biology
216
Noncoding RNA
160
Brain Neurological Disorders
157
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
4,056
Articles tracked across the journal lifetime
Indexed publication set
209
188 cited publications
Last 12 months
225
18.8 publications/month
Open access share
100.0%
225 OA publications in the last year
Leading citing country
China
637 citing publications
Leading citing field
Neurodegenerative Disorders
553 citing publications
Latest tracked publication
11 October 2026
10 recent records available
Coverage & Indexing History
v1n1, 1981-
v1n1, 1981-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Neurodegenerative Disorders
Neurosciences
Noncoding RNA
Immunology
Genetics & Genomics
Mitochondria
Broad Categories
Cell Biology
Molecular Biology
Neurology
Neurodegenerative Disorders
Noncoding RNA
Neurosciences
Cancer, Autophagy & Apoptosis
Musculoskeletal Disorders
Neuromuscular Disorders
MeSH Descriptors
Cell Biology
Molecular Biology
Neurons
Neurophysiology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1007/s10571-026-01844-1
Open DOI
NDRG2 as a Promising Therapeutic Target in Depression: A Review of its Multifaceted Mechanisms
02
DOI 10.1007/s10571-026-01842-3
Open DOI
Cell Adhesion Molecule 1-Targeting Antibodies Enhance Nose-to-Brain Delivery of Monomethyl Auristatin E
03
DOI 10.1007/s10571-026-01839-y
Open DOI
Oligodendroglial α-Synucleinopathy Remodels Transcriptional Programs Associated with Nigral Vulnerability in Experimental Multiple System Atrophy
Multiple system atrophy (MSA) is characterized by oligodendroglial α-synucleinopathy and selective degeneration of striatonigral and olivopontocerebellar systems, but the molecular events associated with regional vulnerability remain inc...
04
DOI 10.1007/s10571-026-01824-5
Open DOI
Knock-Out of Prion Protein Associated with Reactivity and Mitochondrial Abnormalities in a Novel Human Astrocyte Model
05
DOI 10.1007/s10571-026-01840-5
Open DOI
Astrocytic Lipid Dysregulation in Amyotrophic Lateral Sclerosis
Although amyotrophic lateral sclerosis (ALS) has traditionally been viewed as a motor neuron-centered disease manifesting by muscle wasting and weakness, growing evidence indicates that disease progression is strongly influenced by inter...
06
07
DOI 10.1007/s10571-026-01832-5
Open DOI
The Impact of a Short-Term Reduction in CD8+ T Cells on Aged APP/PS1 Mice
CD8⁺ T cells infiltrate the brain parenchyma of patients with Alzheimer’s disease (AD), where they localize near microglia and neurons. Although recent studies have revealed that they can clonally expand and possess a unique phenotype, t...
08
09
10
DOI 10.1007/s10571-026-01834-3
Open DOI
β-Hydroxybutyrate Maintains Energetically Demanding Neural Functions During Exogenous Glucose Deprivation
Bibliographical & Catalog Notes
Title from cover.
Also issued online.
(1989)19890818 Notice not published Printed on acid-free paper